{
  "trial_id": "NCT00452166",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "CKD stage 4",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "BMI \u2264 30",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Fasting glucose < 7 mmol/l",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Diabetes mellitus for which the patient uses insulin",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Significant co-morbidities which, according to the treating nephrologists, makes it unlikely that the patient will be able to complete the foreseen study period",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient has a documented positive serum MPO-ANCA and is being treated with corticosteroid and cyclophosphamides. His Birmingham Vasculitis Activity Score (BVAS) is above 4.",
  "_meta": {
    "topic_id": "54",
    "trial_id": "NCT00452166",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}